Biotech company developing bioprinted tissue therapeutics to transform how we treat disease.
Aspect Biosystems has raised $56.8M in total funding. The most recent round was Grant. The last funding was announced in April 2026.
Aspect Biosystems's investors include Radical Ventures, Government of Canada, Novo Nordisk, Innovate BC, Pangaea Ventures.
Aspect Biosystems is headquartered in Vancouver, Canada.
Biotech company developing bioprinted tissue therapeutics to transform how we treat disease.
Aspect Biosystems is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aspect Biosystems — Funding & Investors." VCBacked, April 2, 2026, https://www.vcbacked.co/company/aspect-biosystems. Accessed July 19, 2026.
VCBacked. (2026). Aspect Biosystems — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/aspect-biosystems
{{cite web |title=Aspect Biosystems — Funding & Investors |url=https://www.vcbacked.co/company/aspect-biosystems |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated